glp-1 agonists ozempic New GLP-1; Semaglutide (Ozempic) Lower doses of the GLP-1
Description
The phase 2a liver-specific trial showed: 1 mg dose: 42.9% reduction in liver fat 4 mg dose: 57.0% reduction in liver fat 8 mg dose: 81.4% reduction in liver fat 12 mg dose: 82.4% reduction in liver fat An 82% reduction in liver fat is extraordinary
[DOI] [PubMed] [Google Scholar] 105
Your provider will guide the transition
Zatorski H, Saaga M, Fichna J
doi: 10.1097/CM9.0000000000001712 [DOI] [PMC free article] [PubMed] [Google Scholar] 202
